The United States will likely move to resume Johnson & Johnson’s COVID-19 vaccine this coming week, possibly with restrictions or broader warnings after reports of some very rare blood clot cases, the government’s top infectious diseases expert said Sunday.
The new effort, which relies on money approved by Congress as part of President Joe Biden’s coronavirus relief package, aims to break what experts say is a feast-or-famine cycle in U.S. preparedness for biological threats, of which the coronavirus is only one example.
Nearly half of American adults have gotten at least one dose of the vaccine, and about 30% of adults in the U.S. have been fully vaccinated, according to the Centers for Disease Control and Prevention.
As many as 60 countries might be stalled at the first shots of their coronavirus vaccinations because nearly all deliveries through the global program intended to help some of the world's poorest nations are blocked until as late as June.
World Health Organization Director-General Tedros Adhanom Ghebreyesus said that on average, one in four people in rich countries has received at least one dose of a COVID-19 vaccine, compared to only one in 500 people in low-income countries.
A patchwork of advice was emerging from governments across Europe and farther afield, a day after the European Union’s drug regulator said there was a “possible link” between the AstraZeneca vaccine and a rare clotting disorder while reiterating the vaccine is safe and effective.
Any further doubts about the AstraZeneca vaccine would be a setback for the shot, which is critical to Europe’s immunization campaign and a linchpin in the global strategy to get vaccines to poorer countries.
The unusual post-infection condition tends to be milder in kids who were sicker with COVID-19, although more than half of affected youngsters received intensive hospital care, according to a CDC analysis.
Three University of Cincinnati students sought a temporary injunction to stop UC from sharing some 46,000 records including Social Security numbers to what they say is a private healthcare provider, UC Health.
Many business owners are keeping their own rules in place, requiring staffers and customers alike to wear masks for the sake of protecting everybody, particularly their employees. And the law is on an owner’s side.